Cyteir completes financing to advance novel cancer therapies

Entrepreneurship
Written By

Cyteir completes financing to advance novel cancer therapies

By David E Shaw

As a co-founder of Cyteir Therapeutics, and chair emeritus of The Jackson Laboratory, I’m pleased to share this news about our Series B financing to advance novel cancer therapies. Cyteir was launched with technological breakthroughs discovered at The Jackson Laboratory.

[wtr_gallery type="alternative" color_bg="004f63" padding="off" id_gallery="7621" animate="none" animate_delay="0"]

Previous

David E Shaw Joins Ocean Elders
Next

Bette Midler Honors David E Shaw at 21st Annual Hulaween Gala